Premaitha Health is a molecular diagnostics company using the latest advances in DNA sequencing technology to develop safer, faster and more accurate clinical tests; initially the IONA non-invasive prenatal test. The company released full-year results to 31 March 2016, with maiden revenues in line with its April trading update and adjusted LBITDA of -£5.3m. We have made adjustments to forecasts given the additional customer wins, with 13 customer labs using IONA by year end and 25 custo
